Are Sirtex's best days behind it?
Sirtex shareholders have been on a rollercoaster ride. But are its latest clinical trial results really as bad as they look?
IRESS targets UK market
IRESS is looking for growth in the UK wealth management market, but it will have to deal with the regulatory threat to its core adviser market.
Perpetual sees third-quarter inflow
Perpetual has overcome the departure of its Head of Equities and relatively weak recent performance to post another net inflow of funds.
Amalgamated exceeds expectations
Amalgamated has produced far higher returns than we expected, but should you hold on or is it time to cash in?
Betting on Crown - part 2
Crown plans to invest heavily over the next few years, and valuing the company means estimating the impact it will have on earnings.
GBST downgraded to Hold
Financial software provider GBST has gained 16% since we upgraded it to Buy. We're downgrading to Hold.
Austbrokers under review
The insurance broking industry is rapidly changing. It's time for a closer look.
Betting on Crown - part 1
Concerns over capital expenditure requirements and the impact of a Chinese corruption crackdown have created an opportunity in this casino icon.
GBST downgraded to Hold
Financial software provider GBST has gained 10% since we upgraded it to Buy. We're downgrading to Hold.
MYOB: Battle for the cloud
MYOB faces increasing competition with a deteriorating moat. We won't be caught overpaying.
Lloyds is no dark horse
Lloyds's share price is galloping ahead but its dividends are lagging way behind. As Nathan Bell explains, that's about to change.
M2 buys NZ's Call Plus
M2's purchase of New Zealand's number three broadband and fixed voice provider ticks a lot of boxes and the price looks cheap.
Ramsay offers poor value
Australia's largest hospital operator has barely put a foot wrong in more than a decade - but its share price leaves no room for error in the next.
Brickworks, Soul Patts: Interim update
An unprecedented construction boom and the success of TPG Telecom have helped lift the share prices of Soul Patts and Brickworks. What now?
IRESS targets UK wealth
IRESS is looking for growth in the UK wealth management market, but it will have to deal with the regulatory threat to its core adviser market.
Gentrack: Like Hansen, only cheaper
Billing software provider Hansen has returned 54% in five months. If you missed the boat, you may soon get a second chance.
Don't gamble on Crown Subordinated Notes II
As with Crown's casino games, the terms of Notes II are heavily weighted in the company's favour.
GBST's platform for growth
We've missed out on this software provider's gains so far, but we think there should be plenty more to come.
Mining services update HY2015
Revenues have fallen, assets have been written down and share prices have tumbled; mining services remains a dangerous part of the market. But there remains a case for dipping in.
A-REITs expensive on almost every measure
There are no bargains here but if you do own any of the 24 stocks covered in this review, you might want to start thinking about selling them.
GBST's platform for growth
We've missed out on this software provider's gains so far, but we think there should be plenty more to come.
ARB Corp's sales rebound
Sales to the big car companies grew strongly, but higher costs are squeezing margins.
CSL: Australia's best resource stock-Part 2
When you combine a low-cost resource company with non-commodity products, there's plenty of money to be made.
Northern Star: take profits
After a stunning ride that has seen this gold miner's share price triple, it's time to take profits.
Call 1300 880 160
Start a chat
Schedule a call
